Influence of SBRT fractionation on TCP and NTCP estimations for prostate cancer

E. S. Sukhikh, L. G. Sukhikh, A. V. Taletsky, A. V. Vertinsky, P. V. Izhevsky, I. N. Sheino

Research output: Contribution to journalArticle

Abstract

Introduction: Stereotactic body radiation therapy is widely used for the hypofractionated treatment of prostate cancer. The range of total doses used in different clinical trials varies from 33.5 to 50 Gy delivered in 4 or 5 fractions. The choice of an optimal total dose value and fractionation regimen for a particular patient can be carried out using the integral radiobiological criteria, namely tumour control probability (TCP) and normal tissue complication probability (NTCP). In this study, we have investigated the dependence of simulated TCP/NTCP values on total dose in the range of 30–40 Gy delivered in 4 or 5 fractions for patients with low-risk prostate cancer in order to find the optimal total dose value and fractionation regimen. Methods: The anatomic data (DICOM CT images) of 12 patients with low-risk prostate cancer, who were treated at Tomsk Regional Oncology Centre, were used for the calculation. Dosimetric treatment plans for all patients were simulated using VMAT with 2 arcs in the Monaco treatment planning system v5.10 (Elekta Instrument AB, Stockholm) with a total dose equal to 36.25 Gy. The dosimetric plans were rescaled in the dose range of 30–40 Gy. The TCP and NTCP values were calculated based on differential dose volume histograms using the Niemierko model for both TCP and NTCP, and the Källman-s model for NTCP calculations. The TCP calculation was carried out using the uncertainty of well-known tumour radiobiological parameters values, including α/β value. NTCP was calculated for an anterior rectal wall, which was the most irradiated organ at risk due to its close contact with the planning target volume. Results: The TCP and NTCP calculations for VMAT of the prostate cancer have shown that the optimal total dose ranges were equal to 32–34 Gy delivered in 4 fractions or 35–38 Gy delivered in 5 fractions. At doses lower than the optimal ones, the TCP values were lower than 95%, while TCP uncertainties were significant (as low as 80%). This fact might bring unexpectedly poor treatment results. At doses higher than optimal ones, the probability of toxicity to the anterior rectal wall became significant. Conclusion: The optimization of radiation therapy regimen based on TCP/NTCP criteria could help to determine an optimal total dose and a number of fractions for a particular patient depending on patient-specific anatomic features and planned dose distribution.

Original languageEnglish
Pages (from-to)41-46
Number of pages6
JournalPhysica Medica
Volume62
DOIs
Publication statusPublished - 1 Jun 2019

Fingerprint

fractionation
Prostatic Neoplasms
tumors
cancer
dosage
Neoplasms
Dose Fractionation
Uncertainty
planning
radiation therapy
Monaco
Radiotherapy
Organs at Risk
Therapeutics
histograms
toxicity
organs

Keywords

  • Hypofractionated radiotherapy
  • Prostate cancer
  • Radiobiological simulation
  • Volumetric modulated arc therapy

ASJC Scopus subject areas

  • Biophysics
  • Radiology Nuclear Medicine and imaging
  • Physics and Astronomy(all)

Cite this

Sukhikh, E. S., Sukhikh, L. G., Taletsky, A. V., Vertinsky, A. V., Izhevsky, P. V., & Sheino, I. N. (2019). Influence of SBRT fractionation on TCP and NTCP estimations for prostate cancer. Physica Medica, 62, 41-46. https://doi.org/10.1016/j.ejmp.2019.04.017

Influence of SBRT fractionation on TCP and NTCP estimations for prostate cancer. / Sukhikh, E. S.; Sukhikh, L. G.; Taletsky, A. V.; Vertinsky, A. V.; Izhevsky, P. V.; Sheino, I. N.

In: Physica Medica, Vol. 62, 01.06.2019, p. 41-46.

Research output: Contribution to journalArticle

Sukhikh, ES, Sukhikh, LG, Taletsky, AV, Vertinsky, AV, Izhevsky, PV & Sheino, IN 2019, 'Influence of SBRT fractionation on TCP and NTCP estimations for prostate cancer', Physica Medica, vol. 62, pp. 41-46. https://doi.org/10.1016/j.ejmp.2019.04.017
Sukhikh, E. S. ; Sukhikh, L. G. ; Taletsky, A. V. ; Vertinsky, A. V. ; Izhevsky, P. V. ; Sheino, I. N. / Influence of SBRT fractionation on TCP and NTCP estimations for prostate cancer. In: Physica Medica. 2019 ; Vol. 62. pp. 41-46.
@article{f7646e90f452404bb20dcf8f3e8b6534,
title = "Influence of SBRT fractionation on TCP and NTCP estimations for prostate cancer",
abstract = "Introduction: Stereotactic body radiation therapy is widely used for the hypofractionated treatment of prostate cancer. The range of total doses used in different clinical trials varies from 33.5 to 50 Gy delivered in 4 or 5 fractions. The choice of an optimal total dose value and fractionation regimen for a particular patient can be carried out using the integral radiobiological criteria, namely tumour control probability (TCP) and normal tissue complication probability (NTCP). In this study, we have investigated the dependence of simulated TCP/NTCP values on total dose in the range of 30–40 Gy delivered in 4 or 5 fractions for patients with low-risk prostate cancer in order to find the optimal total dose value and fractionation regimen. Methods: The anatomic data (DICOM CT images) of 12 patients with low-risk prostate cancer, who were treated at Tomsk Regional Oncology Centre, were used for the calculation. Dosimetric treatment plans for all patients were simulated using VMAT with 2 arcs in the Monaco treatment planning system v5.10 (Elekta Instrument AB, Stockholm) with a total dose equal to 36.25 Gy. The dosimetric plans were rescaled in the dose range of 30–40 Gy. The TCP and NTCP values were calculated based on differential dose volume histograms using the Niemierko model for both TCP and NTCP, and the K{\"a}llman-s model for NTCP calculations. The TCP calculation was carried out using the uncertainty of well-known tumour radiobiological parameters values, including α/β value. NTCP was calculated for an anterior rectal wall, which was the most irradiated organ at risk due to its close contact with the planning target volume. Results: The TCP and NTCP calculations for VMAT of the prostate cancer have shown that the optimal total dose ranges were equal to 32–34 Gy delivered in 4 fractions or 35–38 Gy delivered in 5 fractions. At doses lower than the optimal ones, the TCP values were lower than 95{\%}, while TCP uncertainties were significant (as low as 80{\%}). This fact might bring unexpectedly poor treatment results. At doses higher than optimal ones, the probability of toxicity to the anterior rectal wall became significant. Conclusion: The optimization of radiation therapy regimen based on TCP/NTCP criteria could help to determine an optimal total dose and a number of fractions for a particular patient depending on patient-specific anatomic features and planned dose distribution.",
keywords = "Hypofractionated radiotherapy, Prostate cancer, Radiobiological simulation, Volumetric modulated arc therapy",
author = "Sukhikh, {E. S.} and Sukhikh, {L. G.} and Taletsky, {A. V.} and Vertinsky, {A. V.} and Izhevsky, {P. V.} and Sheino, {I. N.}",
year = "2019",
month = "6",
day = "1",
doi = "10.1016/j.ejmp.2019.04.017",
language = "English",
volume = "62",
pages = "41--46",
journal = "Physica Medica",
issn = "1120-1797",
publisher = "Associazione Italiana di Fisica Medica",

}

TY - JOUR

T1 - Influence of SBRT fractionation on TCP and NTCP estimations for prostate cancer

AU - Sukhikh, E. S.

AU - Sukhikh, L. G.

AU - Taletsky, A. V.

AU - Vertinsky, A. V.

AU - Izhevsky, P. V.

AU - Sheino, I. N.

PY - 2019/6/1

Y1 - 2019/6/1

N2 - Introduction: Stereotactic body radiation therapy is widely used for the hypofractionated treatment of prostate cancer. The range of total doses used in different clinical trials varies from 33.5 to 50 Gy delivered in 4 or 5 fractions. The choice of an optimal total dose value and fractionation regimen for a particular patient can be carried out using the integral radiobiological criteria, namely tumour control probability (TCP) and normal tissue complication probability (NTCP). In this study, we have investigated the dependence of simulated TCP/NTCP values on total dose in the range of 30–40 Gy delivered in 4 or 5 fractions for patients with low-risk prostate cancer in order to find the optimal total dose value and fractionation regimen. Methods: The anatomic data (DICOM CT images) of 12 patients with low-risk prostate cancer, who were treated at Tomsk Regional Oncology Centre, were used for the calculation. Dosimetric treatment plans for all patients were simulated using VMAT with 2 arcs in the Monaco treatment planning system v5.10 (Elekta Instrument AB, Stockholm) with a total dose equal to 36.25 Gy. The dosimetric plans were rescaled in the dose range of 30–40 Gy. The TCP and NTCP values were calculated based on differential dose volume histograms using the Niemierko model for both TCP and NTCP, and the Källman-s model for NTCP calculations. The TCP calculation was carried out using the uncertainty of well-known tumour radiobiological parameters values, including α/β value. NTCP was calculated for an anterior rectal wall, which was the most irradiated organ at risk due to its close contact with the planning target volume. Results: The TCP and NTCP calculations for VMAT of the prostate cancer have shown that the optimal total dose ranges were equal to 32–34 Gy delivered in 4 fractions or 35–38 Gy delivered in 5 fractions. At doses lower than the optimal ones, the TCP values were lower than 95%, while TCP uncertainties were significant (as low as 80%). This fact might bring unexpectedly poor treatment results. At doses higher than optimal ones, the probability of toxicity to the anterior rectal wall became significant. Conclusion: The optimization of radiation therapy regimen based on TCP/NTCP criteria could help to determine an optimal total dose and a number of fractions for a particular patient depending on patient-specific anatomic features and planned dose distribution.

AB - Introduction: Stereotactic body radiation therapy is widely used for the hypofractionated treatment of prostate cancer. The range of total doses used in different clinical trials varies from 33.5 to 50 Gy delivered in 4 or 5 fractions. The choice of an optimal total dose value and fractionation regimen for a particular patient can be carried out using the integral radiobiological criteria, namely tumour control probability (TCP) and normal tissue complication probability (NTCP). In this study, we have investigated the dependence of simulated TCP/NTCP values on total dose in the range of 30–40 Gy delivered in 4 or 5 fractions for patients with low-risk prostate cancer in order to find the optimal total dose value and fractionation regimen. Methods: The anatomic data (DICOM CT images) of 12 patients with low-risk prostate cancer, who were treated at Tomsk Regional Oncology Centre, were used for the calculation. Dosimetric treatment plans for all patients were simulated using VMAT with 2 arcs in the Monaco treatment planning system v5.10 (Elekta Instrument AB, Stockholm) with a total dose equal to 36.25 Gy. The dosimetric plans were rescaled in the dose range of 30–40 Gy. The TCP and NTCP values were calculated based on differential dose volume histograms using the Niemierko model for both TCP and NTCP, and the Källman-s model for NTCP calculations. The TCP calculation was carried out using the uncertainty of well-known tumour radiobiological parameters values, including α/β value. NTCP was calculated for an anterior rectal wall, which was the most irradiated organ at risk due to its close contact with the planning target volume. Results: The TCP and NTCP calculations for VMAT of the prostate cancer have shown that the optimal total dose ranges were equal to 32–34 Gy delivered in 4 fractions or 35–38 Gy delivered in 5 fractions. At doses lower than the optimal ones, the TCP values were lower than 95%, while TCP uncertainties were significant (as low as 80%). This fact might bring unexpectedly poor treatment results. At doses higher than optimal ones, the probability of toxicity to the anterior rectal wall became significant. Conclusion: The optimization of radiation therapy regimen based on TCP/NTCP criteria could help to determine an optimal total dose and a number of fractions for a particular patient depending on patient-specific anatomic features and planned dose distribution.

KW - Hypofractionated radiotherapy

KW - Prostate cancer

KW - Radiobiological simulation

KW - Volumetric modulated arc therapy

UR - http://www.scopus.com/inward/record.url?scp=85065058506&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85065058506&partnerID=8YFLogxK

U2 - 10.1016/j.ejmp.2019.04.017

DO - 10.1016/j.ejmp.2019.04.017

M3 - Article

AN - SCOPUS:85065058506

VL - 62

SP - 41

EP - 46

JO - Physica Medica

JF - Physica Medica

SN - 1120-1797

ER -